Filing Details
- Accession Number:
- 0001209191-22-003395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-14 20:30:16
- Reporting Period:
- 2020-03-01
- Accepted Time:
- 2022-01-14 20:30:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1718108 | Surface Oncology Inc. | SURF | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283882 | Alison Oneill | C/O Surface Oncology, Inc. 50 Hampshire Street, 8Th Floor Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-01 | 45,000 | $0.00 | 45,000 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-07-21 | 14,809 | $6.10 | 30,191 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in full on the date 18 months after January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such date.
- Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.
Billionaire Hedge Funds
